FDA Issues Draft Guidance on Custom Device Exemption Implementation

The U.S. Food and Drug Administration has issued draft guidance regarding the implementation of the custom device exception in the Food, Drug and Cosmetic Act.

Advertisement

The guidance offers definitions, information on what should be submitted in a Custom Device Annual Report and other recommendations on submitting the annual report.

The FDA is accepting comments on the draft guidance for the next 60 days.

To view the draft guidance in full, please click here.

More Articles on the FDA:

FDA Approves First Gel Sealant for Leaking Cornea After Cataract Surgery
FDA Recalls Covidien’s Puritan Bennett 840 Ventilator
FDA, Google X Researchers Meet, Spur Rumors of New Device

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.